Laboratories Aron

Laboratoires Aron was a prominent French pharmaceutical company that specialized in the research and development of therapies for neuropsychiatry, cardiology, and metabolic disorders. The company is most recognized for developing Survector (amineptine), a unique dopaminergic antidepressant that saw significant use in Europe and other regions. Founded as a family-owned enterprise, it established a strong reputation in the mid-20th century for its innovative approach to small molecule drug discovery. In 1983, the company was acquired by Synthelabo, which subsequently merged with Sanofi in 1999. Today, Laboratoires Aron exists as a legacy brand within the Sanofi corporate structure, having contributed several important compounds to the global pharmaceutical market.